Bicycle Therapeutics plc
BCYC
$4.10
$0.092.24%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.78% | -29.54% | -50.75% | -46.56% | -20.85% |
| Total Depreciation and Amortization | -17.24% | -10.48% | -4.69% | 8.49% | 7.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.36% | 26.27% | -9.11% | -26.53% | -21.24% |
| Change in Net Operating Assets | -268.88% | -126.48% | 65.43% | 92.79% | -137.88% |
| Cash from Operations | -27.19% | -51.57% | -18.31% | -27.21% | -111.82% |
| Capital Expenditure | -34.59% | -90.28% | -133.55% | -93.40% | -116.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -34.59% | -90.28% | -133.55% | -93.40% | -116.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.40% | 99.47% | 99.49% | -- | -- |
| Issuance of Common Stock | -99.99% | -99.99% | -99.95% | -99.97% | 120.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.03% | -100.03% | -99.98% | -104.04% | 107.82% |
| Foreign Exchange rate Adjustments | -946.32% | 215.85% | -131.78% | 1,086.04% | -60.17% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -169.48% | -171.18% | -176.08% | -138.60% | 105.20% |